MLH1 and neoplasm: MSI CRC in Western population groups are shown to dominantly occur in female patients with right-sided tumours, a serrated morphology and BRAFV600E mutations, MLH1 protein loss due to promoter methylation and a high CIMP molecular phenotype2,20.